In Vitro ADME Services
Creative Biolabs offers a comprehensive range of tailored in vitro ADME services, including professional testing design, GLP-based in vitro ADME testing, and data analysis, to help you characterize the ADME properties of your drug candidate and its interaction function. Our high-throughput ADME screening platforms provide rapid and efficient testing capabilities to ensure the highest level of precision, reproducibility, and consistency in our results. Our experienced team has strong problem-solving skills that enable us to perform a variety of in vitro ADME screening tests and assist clients in coming up with a solution that suits their drug discovery needs.
Introduction What We Can Offer Types of Our Services Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Comprehensive and Tailored In Vitro ADME Services
In vitro ADME studies are foundational to modern drug discovery, providing controlled, mechanistic data on how a compound interacts with biological systems outside of a living organism. Performing early in vitro ADME test is a way to better understand the absorption, distribution, mode of action (MOA), metabolism, excretion (ADME), and pharmacokinetic (PK) properties of a compound. These properties are very critical for selecting the proper drug candidates for later experiments.
Inquire regarding partnership potential - Request a consultation.
Fig.1 The Principles of ADME.
What We Can Offer
Lead Optimization (LO) and SAR Guidance
Efficiently inform chemical structure-activity relationship (SAR) studies by providing rapid, predictive data on key liabilities, thereby guiding molecular modification and subsequent synthesis endeavors.
Risk Mitigation and Attrition Reduction
Proactively identify compounds with poor predicted bioavailability or high metabolic instability, significantly reducing the probability of failure during expensive in vivo and costly clinical development phases.
Predicting Human Pharmacokinetics
Utilize robust In Vitro- In Vivo extrapolation (IVIVE) models, derived from comprehensive metabolic and binding data, to forecast human systemic clearance and appropriate initial human dosing strategies.
Understanding Target-Site Exposure
Determine the unbound drug fraction through plasma and tissue protein binding assays, allowing for a more accurate assessment of the concentration available at the intended therapeutic target site.
Our In Vitro ADME Services
In Vitro ADME Screening
-
Comprehensive early-phase profiling employs key physicochemical, stability, and transporter assays to facilitate prompt candidate risk assessment and effective subsequent optimization strategies.
High-Throughput ADME
-
Rapidly assesses foundational properties like preliminary solubility and metabolic stability, enabling fast triage of large compound libraries during lead selection.
Distribution
-
CaCo-2 & MDCK Permeability
-
PAMPA (GIT, BBB and Skin)
-
Influx Transporters
-
Plasma / Blood Partitioning
-
Blood Brain Barrier Penetration
Others
-
Cell Proliferation & Cytoxicity
-
Mechanism PK Study
-
In Vitro Toxicity
-
hERG Inhibition
Highlights
Accelerated Screening Capacity
Our HTS platforms are engineered for the rapid and efficient processing of a substantial volume of samples. This capability dramatically streamlines the drug discovery timeline and enables accelerated prioritization of lead candidates.
Uncompromising Data Quality
Advanced automation and validated systems ensure the delivery of results that are consistently accurate, highly reproducible, and rigorously reliable. This technological rigor provides dependable data for critical development decisions.
Flexible Customization
Creative Biolabs offers fully customizable services to meticulously align with unique project specifications and diverse therapeutic modalities. We tailor assay parameters to meet specific client needs throughout the discovery process.
Integrated Scientific Support
Our team of experienced scientists furnishes comprehensive technical assistance, offering guidance on experimental design, data analysis, and expert interpretation to facilitate strategic project advancement.
Initiate partnership - Submit a quotation request.
Customer Reviews
-
High Clearance Compounds
The utilization of Creative Biolabs' in Vitro ADME service in research programs has significantly enhanced the confidence level in IVIVE predictions. The combined application of liver cells offers a comprehensive metabolic disposition characterization. – M*l G*r.
-
Early Safety Screening
Integrating preliminary safety screens like cardiotoxicity and genotoxicity concurrently with solubility testing was invaluable. This capability allowed us to eliminate a toxic lead candidate early, achieving significant fiscal savings. – A*a V*z.
FAQs
Q: How early should the Creative Biolabs in vitro ADME services be integrated into a discovery process?
A: Early integration of initial screening is advised during lead identification to proactively assess risks. This ensures resources are focused on compounds with optimal properties, resulting in considerable cost and time savings.
Q: What is the principal advantage of utilizing fresh cryopreserved hepatocytes over liver microsomes for stability testing?
A: Whole liver cells offer a physiologically comprehensive model, measuring total compound clearance via both major and minor metabolic pathways. This facilitates more precise prediction of systemic drug disposition than simpler cellular components.
Related Services
LC-MS-based Bioanalysis
Provides quantitative measurement of drug concentrations and metabolites in complex biological matrices using high-resolution mass spectrometry platforms.
Learn More →
In Vivo PK
Offers expertise in formulating compounds for in vivo administration and assessing the physical/chemical stability of the drug product.
Learn More →
How to Contact Us
Creative Biolabs' years of expertise and proprietary LC-MS-based technologies enable us to gain insight into your ADME analysis development, accelerate your data collection, and help you interpret the results. We are devoted to accelerating and enhancing your drug discovery, allowing you to identify the most promising hit compounds for the next immunotherapy-based cancer treatment.
For more information, please contact us.
For Research Use Only | Not For Clinical Use
